Paper Details
- Home
- Paper Details
Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
Author: BrownJoelle, DartehSarah, GoslingRoland, HwangJimee, KuneneSimon, MalambeCalisile, MaphalalaGugu, MkhontaNomcebo, MwandemeleAsen, NtshalintshaliNyasatu, PaceCheryl, PanSisi, PoirotEugenie, SobleAdam, StergachisAndy, VilakatiSibonakaliso, VittinghoffEric
Original Abstract of the Article :
Countries remain reluctant to adopt the 2012 World Health Organization recommendation for single low-dose (0.25 mg/kg) primaquine (SLD PQ) for Plasmodium falciparum transmission-blocking due to concerns over drug-related haemolysis risk, especially among glucose-6-phosphate dehydrogenase-deficient (...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957931/
データ提供:米国国立医学図書館(NLM)
Pharmacovigilance for Safe Rollout of Primaquine: A Pilot Study in Swaziland
This study explores the potential of using pharmacovigilance methods to monitor the safety of single low-dose primaquine (SLD PQ) for the treatment of malaria in Swaziland. SLD PQ is a promising antimalarial drug but has been associated with drug-related hemolysis risk, particularly among individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd). The study aimed to develop a pharmacovigilance tool to collect safety data and support the safe rollout of SLD PQ in Swaziland.
Pharmacovigilance: A Key to Safe Drug Deployment
The study highlights the importance of pharmacovigilance in ensuring the safe and effective deployment of new drugs, particularly in resource-limited settings where access to healthcare may be limited. Pharmacovigilance methods provide a systematic approach to monitoring drug safety and identifying potential risks early on, enabling timely interventions and protecting public health.
Pharmacovigilance: Navigating the Desert of Drug Safety
Imagine a caravan traversing a vast desert, carrying precious resources. To ensure their safe journey, the caravan relies on skilled guides who navigate treacherous terrain, identify potential hazards, and ensure the well-being of the travelers. This analogy captures the role of pharmacovigilance in drug deployment, where careful monitoring and data collection are essential to ensure the safe and effective use of medications.
Dr.Camel's Conclusion
This study underscores the importance of pharmacovigilance in supporting the safe rollout of new drugs, particularly in resource-limited settings. The pilot study in Swaziland provides valuable insights into the development and implementation of effective pharmacovigilance systems, ensuring that new drugs are deployed safely and effectively to benefit the populations that need them most.
Date :
- Date Completed 2017-05-22
- Date Revised 2019-12-10
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.